Comparison of pivmecillinam and cephalexin in acute uncomplicated urinary tract infection

International Journal of Antimicrobial Agents

Volumn 13, Issue 3, 2000, Pages 183-187

  Menday, A P ^a  

^a Leo Pharmaceuticals   (United Kingdom)

Author keywords

Cephalexin; Pivmecillinam; Treatment; Urinary tract infection

Indexed keywords

CEFALEXIN; PIVMECILLINAM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESCHERICHIA COLI; ESOPHAGITIS; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY TRACT INFECTION; URINE CULTURE; VERTIGO; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMDINOCILLIN PIVOXIL; BACTERIAL INFECTIONS; CEPHALEXIN; CYSTITIS; DOUBLE-BLIND METHOD; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUSHING; HOT FLASHES; HUMANS; MALE; MIDDLE AGED; NAUSEA; URINARY TRACT INFECTIONS;

EID: 0033990839     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00118-1     Document Type: Article

References (18)

1. Select Committee on Science and Technology. Sub-committee 1 (House of Lords), 7th report (session 1997-8): resistance to antibiotics and other antimicrobial agents, [HL]81-1. The Stationery Office, London, 1998.
2. Standing Medical Advisory Committee (Department of Health). The path of least resistance, Main report. Department of Health, London, 1998.
3. Rosdahl, V.T., Pedersen, K.B., editors. The Copenhagen Recommendations. Report from the Invitational EU Conference on the Microbial Threat, 9-10 September, Copenhagen, Denmark. Ministry of Health, Ministry of Food, Agriculture and Fisheries, Denmark, 1998.
4. Wise R., Hart T., Cars O. et al. Antimicrobial resistance is a major threat to public health. Br. Med. J. 317:1998;609-610.
5. Sutlieff P.A. A comparison between a 3-day and a 5-day course of pivmecillinam as a treatment for acute lower urinary tract infection in general practice. Curr. Med. Res. Opin. 7:1982;563-568.
6. Richards H.H. Comparative efficacy of 3-day and 7-day chemotherapy with twice-daily pivmecillinam in urinary tract infections seen in general practice. Curr. Med. Res. Opin. 9:1984;197-203.
7. ®) in the treatment of acute cystitis. Comparison of three and seven days' treatment. Ugerskr. Laeg. 143:1981;670-673.
8. Hovelius B., Mardh P.A., Nygaard-Pedersen L., Wathne B. Nalidixic acid and pivmecillinam for treatment of acute lower urinary tract infections. Scand. J. Primary Health Care. 3(Suppl 4):1985;227-232.
9. Pitkajarvi T., Pyykonen M.-L., Kannisto K., Piippo T., Viita P. Pivmecillinam treatment in acute cystitis. Drug Res. 40:1990;1156-1158.
10. Performance standards for antimicrobic disc susceptibility tests. National Committee for Clinical Laboratory Standards, 1979.
11. The clinical evaluation of antibacterial drugs. J. Antimicrob. Chemother. 23(suppl. B):1989;1-42.
12. Donald J.F., Rimmer D.M.D. An open evaluation of a 3-day course of pivmecillinam (ten 200 mg tablets) in women with uncomplicated ystitis. J. Int. Med. Res. 8:1980;112-117.
13. ®) and a six day course of sulphamethizide. J. Drug Ther. Res. 9:1984;26-28.
14. Ashby J.P., Andrews J.M., Wise R. Development of a standardised method of disc testing to determine the sensitivity of mecillinam to UTI pathogens using methodology based on the BSAC standardised method of disc testing. J. Antimicrob. Chemother. 44(suppl. A):1999;122.
15. Cars O (Ed.). Antimicrobial Susceptibility Testing in Sweden. Scand J Infect Dis 1997;105(suppl 3).
16. BSAC Standardised disc sensitivity testing method. Newsletter of the British Society for Antimicrobial Chemotherapy (Bermingham). Summer 1998.
17. Winstanley T.G., Linb D.I., Eggington R., Hancock F. A 10-year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: the Microbe Base project. J. Antimicrob. Chemother. 40:1997;591-594.
18. Piddock L.J.V. Fluoroquinolone resistance. Br. Med. J. 317:1998;1029-1030.